Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stocking, C. B.
Right arrow Articles by Sachs, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stocking, C. B.
Right arrow Articles by Sachs, G. A.
Related Collections
Right arrow All Clinical trials
Right arrow All Cognitive Disorders/Dementia
Right arrow All Ethics in Neurology/Legal issues
NEUROLOGY 2003;61:1649-1651
© 2003 American Academy of Neurology


Contemporary Issues

Are the rules for research with subjects with dementia changing?

Views from the field

Carol B. Stocking, PhD, Gavin W. Hougham, MA, Aliza R. Baron, AM and Greg A. Sachs, MD

From the Section of Geriatrics (Drs. Stocking and Sachs, G.W. Hougham and A.R. Baron) and MacLean Center for Clinical Medical Ethics (Dr. Stocking), Department of Medicine, University of Chicago, IL.

Address correspondence and reprint requests to Dr. C.B. Stocking, MacLean Center for Clinical Medical Ethics, Department of Medicine, University of Chicago, 5841 S. Maryland Ave. (MC 6098), Chicago, IL 60637; e-mail: cstockin{at}medicine.bsd.uchicago.edu

Deliberative bodies have recommended additional protections for persons with dementia included in clinical trials. This survey of experienced dementia researchers revealed that 45 to 64% considered that specific ones of these recommendations would increase subject protection, and 40 to 86% considered they would make research less feasible. The real tradeoff between protection and difficulty in conducting research on devastating illnesses needs to be confronted when new regulations in this area are debated.


Received April 18, 2003. Accepted in final form September 11, 2003.

See also pages 1645 and 1662

Presented in part at the November 2002 meeting of the Gerontological Society of America.




This article has been cited by other articles:


Home page
J. Med. EthicsHome page
J Warner, R McCarney, M Griffin, K Hill, and P Fisher
Participation in dementia research: rates and correlates of capacity to give informed consent
J. Med. Ethics, March 1, 2008; 34(3): 167 - 170.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Y.H. Kim and J. H.T. Karlawish
Ethics and politics of research involving subjects with impaired decision-making abilities
Neurology, December 23, 2003; 61(12): 1645 - 1646.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.